Pyridoxine and dietary counseling for the management of idiopathic hyperoxaluria in stone-forming patients

Urology

Volumn 77, Issue 5, 2011, Pages 1054-1058

  Ortiz Alvarado, Omar ^a,b   Miyaoka, Ricardo ^a,b   Kriedberg, Carly ^a,b   Moeding, Angela ^a,b   Stessman, Michelle ^a,b   Monga, Manoj ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXALIC ACID; PYRIDOXINE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CALCIUM INTAKE; CLINICAL EFFECTIVENESS; DIET THERAPY; DRUG DOSE TITRATION; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HYPEROXALURIA; IDIOPATHIC HYPEROXALURIA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; PATIENT COUNSELING; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SODIUM RESTRICTION; URINALYSIS; URINARY EXCRETION; URINE LEVEL; URINE VOLUME; VITAMIN SUPPLEMENTATION;

COMBINED MODALITY THERAPY; DIRECTIVE COUNSELING; FEMALE; HUMANS; HYPEROXALURIA; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PYRIDOXINE; RETROSPECTIVE STUDIES; URINARY CALCULI;

EID: 79955613592     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.08.002     Document Type: Article

References (30)

1. Mandel G, Mandel N. Analysis of stones. In: Coe FL, et al, eds Kidney Stones: Medical and Surgical Management. Philadelphia: Lippincot-Raven; 1996.
2. Holmes RP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int. 2001;59:270-276. (Pubitemid 32055235)
3. Krishnamurthy MS, Hruska KA, Chandhoke PS. The urinary response to an oral oxalate load in recurrent calcium stone-forming patients. J Urol. 2003;169:2030-2033. (Pubitemid 36576710)
4. Holmes RP, Assimos DG. Glyoxylate synthesis, and its modulation and influence on oxalate synthesis. J Urol. 1998;160:1617-1624.
5. Williams HE, Wandzilak TR. Oxalate synthesis, transport and the hyperoxaluric syndromes. J Urol. 1989;141:742-747.
6. Scheinman JI, Voziyan PA, Belmont JM, et al. Pyridoxamine lowers oxalate excretion and kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria. Urol Res. 2005;33:368-371. (Pubitemid 41752058)
7. Milliner DS, Eickholt JT, Bergstralh EJ, et al. Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med. 1994;331:1553-1558. (Pubitemid 24366902)
8. Asplin JR. Hyperoxaluric calcium nephrolithiasis. Endocrinol Metab Clin North Am. 2002;31:927-949. (Pubitemid 35403491)
9. Penniston KL, Nakada SY. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation. Urology. 2009;73:484-489.
10. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346:77-84. (Pubitemid 34438897)
11. Siener R, Schade N, Nicolay C, et al. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate patients. J Urol. 2005;173:1601-1605. (Pubitemid 40524783)
12. Siener R, Ebert D, Nicolay C, et al. Dietary risk factors for hyperoxaluria in calcium oxalate stone-forming patients. Kidney Int. 2003;63:1037-1043. (Pubitemid 36315582)
13. Hesse A, Schneeberger W, Engfeld S, et al. Intestinal hyperabsorption of oxalate in calcium oxalate stone-forming patients: application of a new test with [13C2] oxalate. J Am Soc Nephrol. 1999; 10:S329-S333. (Pubitemid 29498574)
14. Nguyen QV, Kälin A, Drouve U, et al. Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone-forming patients. Kidney Int. 2001;59:2273-2281. (Pubitemid 32467621)
15. Bai SC, Sampson DA, Morris JG, et al. The level of dietary protein affects vitamin B6 requirements in cats. J Nutr. 1991;121:1054-1061.
16. Breslau NA, Brinkley L, Hill KD, et al. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab. 1988;66:140-146. (Pubitemid 18027743)
17. Nouvenne A, Meschi T, Guerra A, et al. Diet to reduce mild hyperoxaluria in patients with idiopathic calcium oxalate stone formation: a pilot study. Urology. 2009;73:725-730.
18. Monico CG, Rossetti S, Olson JB, et al. Pyridoxine effect in type 1 primary hyperoxaluria is associated with the most common mutant allele. Kidney Int. 2005;67:1704-1709. (Pubitemid 40577704)
19. Kaelin A, Casez JP, Jaeger P. Vitamin B6 metabolites in idiopathic calcium stone-forming patients: no evidence to a link for hyperoxaluria. Urol Res. 2004;32:61-68. (Pubitemid 38314149)
20. Alinei P, Guignard JP, Jaeger P. Pyridoxine treatment of type 1 hyperoxaluria. N Engl J Med. 1984;311:798-799. (Pubitemid 14026238)
21. Khan SR, Glenton PA, Byer KJ. Dietary oxalate and calcium nephrolithiasis. J Urol. 2007;178:2191-2196.
22. Curhan GC, Willett WC, Rimm EB, et al. A prospective study of the intakes of vitamins C and B6, and the risk of kidney stones in men. J Urol. 1996;155:1847-1851. (Pubitemid 26144069)
23. Massey LK. Food oxalate: factors affecting measurement, biological variation, and bioavailability. J Am Diet Assoc. 2007;107:1191-1194. (Pubitemid 46976860)
24. Nishijima S, Sugaya K, Morozumi M, et al. Hepatic alanineglyoxylate aminotransferase activity and oxalate metabolism in vitamin B6 deficient rats. J Urol. 2003;169:683-686. (Pubitemid 36133022)
25. Yendt ER, Cohanim M. Response to a physiologic dose of pyridoxine in type 1 primary hyperoxaluria. N Engl J Med. 1985;312:953-957. (Pubitemid 15111955)
26. Nakada T, Sasagawa I, Furuta H, et al. Effect of high calcium diet on urinary oxalate excretion in urinary stone-forming patients. Eur Urol. 1988;15:264-270. (Pubitemid 19006578)
27. Curhan GC, Willett WC, Speizer FE, et al. Intake of vitamin B6 and C and the risk of kidney stones in women. J Am Soc Nephrol. 1999;10:840-845. (Pubitemid 29149535)
28. Berger A, Schaumburg HH. More on neuropathy from pyridoxine abuse. N Engl J Med. 1984;311:986-987. (Pubitemid 14002065)
29. Jaeger P, Portmann L, Jacquet AF, et al. Pyridoxine can normalize oxaluria in idiopathic renal lithiasis. Schweiz Med Wochenschr. 1986;116:1783-1786. (Pubitemid 17202331)
30. Berger AR, Schaumburg HH, Schroeder C, et al. Dose response, coasting, and differential fiber vulnerability in human toxic neuropathy: a prospective study of pyridoxine neurotoxicity. Neurology. 1992;42:1367-1370.